<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02472457</url>
  </required_header>
  <id_info>
    <org_study_id>14-011628</org_study_id>
    <nct_id>NCT02472457</nct_id>
  </id_info>
  <brief_title>Crohn Disease Exclusion Diet After Single Medication De-escalation</brief_title>
  <acronym>CEASE</acronym>
  <official_title>Biologic and Immunomodulator Withdrawal in Pediatric Crohn Disease With Deep Clinical Remission Using the Crohn Disease Exclusion Diet</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital of Philadelphia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Wolfson Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Children's Hospital of Philadelphia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to determine whether pediatric Crohn Disease (CD)
      patients in long-standing remission remain in remission longer after stopping medications if
      they follow the Crohn's Disease Exclusion Diet (CDED). The hypothesis is that subjects on the
      CDED will have longer time-to-relapse as opposed to those on an unrestricted diet.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Crohn disease (CD) is an idiopathic, chronic, relapsing and remitting inflammatory condition
      of the gastrointestinal tract with a high risk for complications and need for surgical
      interventions, particularly in children. Immunomodulators and biologic therapies are
      effective at inducing and maintaining remission in pediatric CD, yet there is no proven
      strategy for reducing exposure to medications once sustained remission has been achieved.
      Diet has been proven to impact disease activity in CD and may allow for sustained drug-free
      remission. The primary objective of this study is to determine whether pediatric CD patients
      in long-standing remission remain in remission longer after stopping medications if they
      follow the Crohn's Disease Exclusion Diet (CDED). The hypothesis is that subjects on the CDED
      will have longer time-to-relapse as opposed to those on an unrestricted diet.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">August 2015</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Actual">May 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sustained Relapse-free Remission</measure>
    <time_frame>At 52 weeks following enrollment</time_frame>
    <description>Remission defined by the Pediatric Crohn Disease Activity Index, C-reactive protein, and stool calprotectin</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time-to-relapse</measure>
    <time_frame>Up to 104 weeks</time_frame>
    <description>Remission defined by the Pediatric Crohn Disease Activity Index, C-reactive protein, and stool calprotectin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Microbial Composition of Gastrointestinal Tract (Types and Quantities of Microorganisms)</measure>
    <time_frame>6 weeks</time_frame>
    <description>Change in the microbial composition of the stool, mouth and rectum from baseline to 6 weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Microbial Composition of Gastrointestinal Tract (Types and Quantities of Microorganisms)</measure>
    <time_frame>52 weeks</time_frame>
    <description>Change in the microbial composition of the stool, mouth and rectum from baseline to 52 weeks</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Dietary Compliance</measure>
    <time_frame>Up to 52 weeks</time_frame>
    <description>Using modified Medication Adherence Rating Scale (MARS) questionnaire</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Crohn Disease</condition>
  <arm_group>
    <arm_group_label>Free Diet</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>No dietary restrictions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Crohn Disease Exclusion Diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The CDED is a palatable diet that excludes foods suspected to have a role in intestinal inflammation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Crohn Disease Exclusion Diet</intervention_name>
    <description>The CDED is divided into 4 stages: 0-6 weeks induction phase, weeks 7-12 step down phase, weeks 13-24 maintenance phase I, and weeks 25-52 maintenance phase II.</description>
    <arm_group_label>Crohn Disease Exclusion Diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Free Diet</intervention_name>
    <description>This diet contains no restrictions.</description>
    <arm_group_label>Free Diet</arm_group_label>
    <other_name>Placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with a diagnosis of Crohn Disease using the Revised Porto criteria who will
             be withdrawing from biologic or immunomodulator monotherapy as part of clinical care.

          -  Normal Growth Velocity, or Tanner 5

          -  Steroid-free Remission (Pediatric Crohn Disease Activity Index Score &lt;10 without the
             height component) for at least 12 months prior to enrollment

          -  Colonoscopy during the preceding 3 months with complete mucosal healing or only few
             aphthous ulcerations located in one segment

          -  Stool calprotectin &lt;250Âµg/g during the preceding 3 months

          -  Parental/guardian permission (informed consent) and, if appropriate, child assent.

        Exclusion Criteria:

          -  Discontinuation of biologic or immunomodulator therapy by the subject without the
             approval of the primary gastroenterologist.

          -  Those subjects who in the judgment of the investigative team are unable to complete
             the study endpoints.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronen Stein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital of Philadelphia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Sigall-Boneh R, Pfeffer-Gik T, Segal I, Zangen T, Boaz M, Levine A. Partial enteral nutrition with a Crohn's disease exclusion diet is effective for induction of remission in children and young adults with Crohn's disease. Inflamm Bowel Dis. 2014 Aug;20(8):1353-60. doi: 10.1097/MIB.0000000000000110.</citation>
    <PMID>24983973</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>June 10, 2015</study_first_submitted>
  <study_first_submitted_qc>June 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 15, 2015</study_first_posted>
  <results_first_submitted>May 11, 2020</results_first_submitted>
  <results_first_submitted_qc>May 11, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">May 27, 2020</results_first_posted>
  <last_update_submitted>July 13, 2020</last_update_submitted>
  <last_update_submitted_qc>July 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 10, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/57/NCT02472457/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Free Diet</title>
          <description>No dietary restrictions
Free Diet: This diet contains no restrictions.</description>
        </group>
        <group group_id="P2">
          <title>Crohn Disease Exclusion Diet</title>
          <description>The CDED is a palatable diet that excludes foods suspected to have a role in intestinal inflammation.
Crohn Disease Exclusion Diet: The CDED is divided into 4 stages: 0-6 weeks induction phase, weeks 7-12 step down phase, weeks 13-24 maintenance phase I, and weeks 25-52 maintenance phase II.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="8">1 subject followed the Specific Carbohydrate Diet</participants>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Free Diet</title>
          <description>No dietary restrictions
Free Diet: This diet contains no restrictions.</description>
        </group>
        <group group_id="B2">
          <title>Crohn Disease Exclusion Diet</title>
          <description>The CDED is a palatable diet that excludes foods suspected to have a role in intestinal inflammation.
Crohn Disease Exclusion Diet: The CDED is divided into 4 stages: 0-6 weeks induction phase, weeks 7-12 step down phase, weeks 13-24 maintenance phase I, and weeks 25-52 maintenance phase II.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="8"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="18"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16.5" spread="3.6"/>
                    <measurement group_id="B2" value="16.0" spread="2.2"/>
                    <measurement group_id="B3" value="16.2" spread="2.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Israel</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Sustained Relapse-free Remission</title>
        <description>Remission defined by the Pediatric Crohn Disease Activity Index, C-reactive protein, and stool calprotectin</description>
        <time_frame>At 52 weeks following enrollment</time_frame>
        <population>1 participant in the free diet group followed the specific carbohydrate diet and was in remission at 52 weeks. 1 participant in the CDED group withdrew prior to 52 weeks.</population>
        <group_list>
          <group group_id="O1">
            <title>Free Diet</title>
            <description>No dietary restrictions
Free Diet: This diet contains no restrictions.</description>
          </group>
          <group group_id="O2">
            <title>Crohn Disease Exclusion Diet</title>
            <description>The CDED is a palatable diet that excludes foods suspected to have a role in intestinal inflammation.
Crohn Disease Exclusion Diet: The CDED is divided into 4 stages: 0-6 weeks induction phase, weeks 7-12 step down phase, weeks 13-24 maintenance phase I, and weeks 25-52 maintenance phase II.</description>
          </group>
        </group_list>
        <measure>
          <title>Sustained Relapse-free Remission</title>
          <description>Remission defined by the Pediatric Crohn Disease Activity Index, C-reactive protein, and stool calprotectin</description>
          <population>1 participant in the free diet group followed the specific carbohydrate diet and was in remission at 52 weeks. 1 participant in the CDED group withdrew prior to 52 weeks.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time-to-relapse</title>
        <description>Remission defined by the Pediatric Crohn Disease Activity Index, C-reactive protein, and stool calprotectin</description>
        <time_frame>Up to 104 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Microbial Composition of Gastrointestinal Tract (Types and Quantities of Microorganisms)</title>
        <description>Change in the microbial composition of the stool, mouth and rectum from baseline to 6 weeks</description>
        <time_frame>6 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Microbial Composition of Gastrointestinal Tract (Types and Quantities of Microorganisms)</title>
        <description>Change in the microbial composition of the stool, mouth and rectum from baseline to 52 weeks</description>
        <time_frame>52 weeks</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Dietary Compliance</title>
        <description>Using modified Medication Adherence Rating Scale (MARS) questionnaire</description>
        <time_frame>Up to 52 weeks</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>52 weeks</time_frame>
      <desc>Adverse event information was obtained via chart review and trial visits</desc>
      <group_list>
        <group group_id="E1">
          <title>Free Diet</title>
          <description>No dietary restrictions
Free Diet: This diet contains no restrictions.</description>
        </group>
        <group group_id="E2">
          <title>Crohn Disease Exclusion Diet</title>
          <description>The CDED is a palatable diet that excludes foods suspected to have a role in intestinal inflammation.
Crohn Disease Exclusion Diet: The CDED is divided into 4 stages: 0-6 weeks induction phase, weeks 7-12 step down phase, weeks 13-24 maintenance phase I, and weeks 25-52 maintenance phase II.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Ronen Stein, MD</name_or_title>
      <organization>The Children's Hospital of Philadelphia</organization>
      <phone>215-590-7801</phone>
      <email>ibdresearch@email.chop.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

